Clinical Trials | November 27, 2025
Cidara hits target enrollment for Phase 3 flu trial ahead of peak season
CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents
CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
A key highlight will be Brenntag’s qualified amino acids portfolio
The European Commission’s green light marks Breyanzi’s fourth indication in Europe and extends access to patients across all EU and EEA countries
Data show adjuvant Verzenio plus endocrine therapy extends overall survival and sustains long-term improvements in invasive disease-free survival
Subscribe To Our Newsletter & Stay Updated
